FTV
NYSE · USDOne year, rebased to 100
FTV SPY XLK (sector ETF) · weekly closesScore DNA
Each bar is a 0-100 score within the scored universeFlags
Smart-money strip
Each disclosure source on its own window. Filings coinciding is not coordination.Key financials · FY2025
USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.Valuation
FTV vs industry median
183 companies in Hardware, Equipment & PartsEarnings delivery
Next report 2026-10-28 · consensus EPS $0.70Peers
Market-cap band, not the industry cohort above| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | 12m return |
|---|---|---|---|---|---|---|
| FTV Fortive Corporation | $17.5B | 33.6x | 8.5% | 12.4% | −17.5% | +18.8% |
| MKSI MKS Inc. | $14.5B | 32.8x | 15.9% | 14.0% | +16.3% | +56.2% |
| TRMB Trimble Inc. | $13.9B | n/m | -1.9% | -48.5% | +5.8% | −23.6% |
| FN Fabrinet | $13.0B | 27.5x | 21.3% | 10.8% | +35.7% | −11.9% |
| TDY Teledyne Technologies Incorp | $28.7B | 29.8x | 9.2% | 15.1% | +7.9% | +10.1% |
| JBL Jabil Inc. | $29.2B | 28.2x | 66.7% | 3.7% | +20.6% | — |
| TTMI TTM Technologies, Inc. | $9.9B | 41.2x | 13.3% | 8.3% | +27.6% | — |
| LFUS Littelfuse, Inc. | $9.7B | n/m | -0.3% | 12.1% | +15.4% | — |
Recent 8-K filings
Context
Full factsheet
The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Narrow).
Read it in the browser Download (PDF)All fundamentals · 140 measures in 13 categories
Percentile = where FTV sits among 41 scored companies in Hardware, Equipment & Parts (0 = lowest value, 100 = highest). It is a position, not a grade.Valuation
| Measure | FTV | Industry percentile |
|---|---|---|
| P/E (TTM) | 32.7x | 36th |
| PEG (P/E ÷ 3-yr EPS CAGR) | — | |
| Price / sales | 4.0x | 60th |
| Price / book | 2.9x | 40th |
| Price / tangible book | — | |
| Price / free cash flow | 18.3x | 22nd |
| Price / operating cash flow | 16.6x | 27th |
| Enterprise value | $20.6B | 78th |
| EV / sales | 4.8x | 70th |
| EV / EBITDA | 17.4x | 33rd |
| EV / EBIT | 25.9x | 47th |
| EV / free cash flow | 21.6x | 38th |
| Earnings yield | 3.1% | 70th |
| FCF yield | 5.5% | 82nd |
| Operating cash flow yield | 6.0% | 75th |
| Graham number (per share) | $27.75 | 24th |
Profitability (TTM)
| Measure | FTV | Industry percentile |
|---|---|---|
| Gross margin | 63.2% | 90th |
| EBITDA margin | 27.5% | 90th |
| Operating margin | 18.2% | 80th |
| EBIT margin | 18.4% | 82nd |
| Net margin | 12.4% | 80th |
| NOPAT margin | 16.3% | 88th |
| FCF margin | 22.1% | 92nd |
| Operating cash flow margin | 24.4% | 90th |
| R&D / revenue | 6.1% | 62nd |
| SG&A / revenue | 38.9% | 95th |
| Stock comp / revenue | 2.5% | 67th |
| Effective tax rate | 10.4% | 15th |
Returns on capital
| Measure | FTV | Industry percentile |
|---|---|---|
| ROE (on average equity) | 6.5% | 32nd |
| ROA | 3.6% | 32nd |
| ROIC | 7.7% | 30th |
| ROCE | 7.7% | 32nd |
| Return on tangible assets | 5.3% | 30th |
| Cash ROIC (OCF / invested capital) | 11.4% | 30th |
| Gross profitability (GP / assets) | 23.5% | 60th |
| ROIC, 3-yr average | 6.2% | 31st |
| ROIC, 5-yr average | 6.3% | 31st |
| ROE, 5-yr average | 7.9% | 31st |
| Incremental ROIC | -0.3% | 36th |
Growth
| Measure | FTV | Industry percentile |
|---|---|---|
| Revenue growth (TTM YoY) | -29.8% | 0th |
| Revenue growth (QoQ) | 2.6% | 10th |
| Revenue CAGR, 3 yr | -10.3% | 0th |
| Revenue CAGR, 5 yr | -3.1% | 3rd |
| Gross profit CAGR, 3 yr | -7.9% | 0th |
| Operating income CAGR, 3 yr | -10.4% | 12th |
| Net income growth (TTM YoY) | -30.5% | 0th |
| Net income CAGR, 3 yr | -12.6% | 10th |
| EPS growth (TTM YoY) | -22.8% | 0th |
| EPS CAGR, 3 yr | -8.3% | 14th |
| EPS CAGR, 5 yr | -19.2% | 6th |
| FCF growth (TTM YoY) | -31.1% | 16th |
| FCF CAGR, 3 yr | -6.9% | 7th |
| Operating cash flow CAGR, 3 yr | -6.6% | 12th |
| Book value CAGR, 3 yr | -11.1% | 3rd |
| Dividend CAGR, 3 yr | -15.8% | 11th |
| Sustainable growth rate | 5.8% | 18th |
Margin history & stability
| Measure | FTV | Industry percentile |
|---|---|---|
| Gross margin, 3-yr average | 60.9% | 89th |
| Operating margin, 3-yr average | 18.4% | 87th |
| Net margin, 3-yr average | 13.1% | 79th |
| FCF margin, 3-yr average | 22.0% | 95th |
| Revenue stability (0-1) | 0.02 | 5th |
| Earnings stability (0-1) | 0.48 | 63rd |
| Margin stability (0-1) | 0.96 | 82nd |
Liquidity (latest quarter)
| Measure | FTV | Industry percentile |
|---|---|---|
| Cash & short-term investments | $374.2M | 48th |
| Net cash (− = net debt) | −$3.1B | 8th |
| Working capital | $310.5M | 25th |
| Current ratio | 1.24 | 10th |
| Quick ratio | 1.00 | 22nd |
| Cash ratio (cash + ST investments / current liabilities) | 0.29 | 22nd |
| Defensive interval (days) | 194 days | 2nd |
Leverage & solvency (latest quarter)
| Measure | FTV | Industry percentile |
|---|---|---|
| Total debt | $3.5B | 85th |
| Debt / equity | 0.58 | 72nd |
| Net debt / equity | 0.52 | 78th |
| Debt / assets | 30.2% | 82nd |
| Debt / capital | 36.7% | 72nd |
| Debt / EBITDA | 2.96 | 78th |
| Net debt / EBITDA | 2.64 | 89th |
| Interest coverage (EBIT / interest) | 6.4x | 47th |
| Cash interest coverage | 8.5x | 38th |
| Debt payback (years of OCF) | 3.3 yrs | 76th |
| Liabilities / assets | 47.8% | 60th |
| IS credit model rating | BBB+ | |
| Implied credit spread (bps) | 225 | 70th |
Efficiency
| Measure | FTV | Industry percentile |
|---|---|---|
| Asset turnover | 0.29 | 5th |
| Fixed asset turnover | 15.40 | 95th |
| Inventory turnover | 3.4 | 54th |
| Receivables turnover | 5.5 | 35th |
| Days sales outstanding | 66 days | 65th |
| Days inventory outstanding | 106 days | 46th |
| Days payables outstanding | 130 days | 100th |
| Cash conversion cycle (days) | 43 days | 10th |
| Capex / revenue | 2.2% | 36th |
| Capex / depreciation | 0.25 | 0th |
| Operating expense ratio | 44.3% | 90th |
Cash flow & earnings quality
| Measure | FTV | Industry percentile |
|---|---|---|
| Operating cash flow / net income | 1.97 | 79th |
| FCF / net income | 1.79 | 82nd |
| FCF / operating cash flow | 90.8% | 92nd |
| Capex / operating cash flow | 9.2% | 8th |
| Accruals ratio | -3.5% | 45th |
| Sloan accruals ratio | -0.1% | 45th |
| Earnings quality score (0-1) | 1.00 | 36th |
Scores & forensic checks
| Measure | FTV | Industry percentile |
|---|---|---|
| IS score | 45 | 15th |
| IS profitability | 51 | 72nd |
| IS growth | 1 | 0th |
| IS value | 45 | 72nd |
| IS momentum | 40 | 3rd |
| IS risk (safety) | 80 | 18th |
| IS quality | 74 | 65th |
| IS balance sheet | 52 | 18th |
| IS earnings quality | 78 | 98th |
| IS cash flow | 59 | 45th |
| Piotroski F-score (0-9) | 6 | 22nd |
| Altman Z-score | 3.4 | 22nd |
| Beneish M-score | −3.15 | 3rd |
| Ohlson O-score | −8.21 | 50th |
| IS credit score | 63 | 25th |
Size (TTM)
| Measure | FTV | Industry percentile |
|---|---|---|
| Market cap | $17.5B | 78th |
| Revenue | $4.3B | 68th |
| EBITDA | $1.2B | 78th |
| Net income | $534.4M | 78th |
| Free cash flow | $954.9M | 82nd |
| Total assets | $11.6B | 82nd |
| Shareholders' equity | $6.1B | 85th |
| Employees | 10,000 | 52nd |
Insider transactions, last 6 months
Form 4 · most recent 12| Date | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-25 | Soroye Olumide Director, President & CEO |
Award / grant | 15 | — | — | 11,968 |
| 2026-09-25 | Okerstrom Mark D SVP - Chief Financial Officer |
Award / grant | 5 | — | — | 3,915 |
| 2026-09-25 | Mulhall Christopher M. VP - Chief Accounting Officer |
Award / grant | 8 | — | — | 6,428 |
| 2026-09-25 | Mulhall Christopher M. VP - Chief Accounting Officer |
Award / grant | 2 | — | — | 1,710 |
| 2026-09-25 | Underwood Peter C SVP - Chief Legal Officer |
Award / grant | 17 | — | — | 13,954 |
| 2026-09-25 | Lassiter Wright Iii Director |
L-Small | 5 | $55.91 | $300 | 25,766 |
| 2026-09-25 | Desjourdy Amee SVP - Chief People Officer |
Award / grant | 1 | — | — | 1,066 |
| 2026-08-10 | Underwood Peter C SVP - Chief Legal Officer |
Open-market sale | 8,662 | $61.59 | $533,493 | 79,118 |
| 2026-07-24 | Okerstrom Mark D SVP - Chief Financial Officer |
Award / grant | 20 | — | — | 3,910 |
| 2026-07-10 | Okerstrom Mark D SVP - Chief Financial Officer |
Award / grant | 20 | — | — | 3,889 |
| 2026-07-06 | Okerstrom Mark D SVP - Chief Financial Officer |
Award / grant | 4 | — | — | 3,869 |
| 2026-07-06 | Soroye Olumide Director, President & CEO |
Award / grant | 11 | — | — | 11,953 |
Shares acquired vs disposed, by month
acquired disposed · all Form 4 typesBy transaction type, 6 months
| Type | Direction | Filings | Shares | Value |
|---|---|---|---|---|
| Award / grant | Acquired | 31 | 37,673 | $442,671 |
| L-Small | Acquired | 2 | 10 | $557 |
| Open-market sale | Disposed | 2 | 56,219 | $3.4M |
| Option exercise | Acquired | 1 | 47,557 | $1.4M |
| Option exercise | Disposed | 1 | 47,557 | $1.4M |
| Tax withholding | Disposed | 1 | 3,777 | $236,629 |
| — | Disposed | 1 | 0 | — |
Form 144 notices
12 months: 10 notices · 161,360 shares · $9.2M| Filed | Filer | Shares proposed | Est. proceeds |
|---|---|---|---|
| 2026-08-10 | Underwood Peter C | 8,662 | $533,493 |
| 2026-06-18 | Branderiz Eric | 15,897 | $981,825 |
| 2026-05-04 | Underwood Peter C | 47,557 | $2.9M |
| 2026-03-23 | Schwarz Jonathan L | 1,692 | $95,133 |
Congress trades
12 months: House 1 trades (1 purchases) · Senate 0 (0 purchases)| Traded | Member | Chamber | Type | Amount | Disclosed |
|---|---|---|---|---|---|
| 2026-07-07 | Ro Khanna | House | Purchase | $1,001 - $15,000 | 2026-08-12 |
| 2025-09-30 | Gilbert Cisneros | House | Sale | $15,001 - $50,000 | 2025-10-13 |
| 2025-09-29 | Gilbert Ray Cisneros | House | Sale (Full) | $15,001 - $50,000 | 2025-10-10 |
| 2025-09-29 | Ro Khanna | House | Purchase | $1,001 - $15,000 | 2025-10-03 |
| 2020-10-09 | Sheldon Whitehouse | Senate | Exchange | $1,001 - $15,000 | 2021-08-06 |
| 2020-10-09 | Sheldon Whitehouse | Senate | Exchange | $1,001 - $15,000 | 2021-08-05 |
| 2020-10-09 | Sheldon Whitehouse | Senate | Exchange | $1,001 - $15,000 | 2020-11-19 |
| 2020-10-09 | Sheldon Whitehouse | Senate | Exchange | $1,001 - $15,000 | 2020-11-18 |
Largest 13F holders
Quarter to 2026-06-30, the latest most managers have filed| Manager | Shares | Value | % of shares out |
|---|---|---|---|
| DODGE & COX | 43,979,772 | $2.7B | 14.56% |
| BlackRock, Inc. | 26,624,052 | $1.6B | 8.82% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 24,384,055 | $1.5B | 8.07% |
| VANGUARD CAPITAL MANAGEMENT LLC | 19,936,606 | $1.2B | 6.60% |
| STATE STREET CORP | 13,620,472 | $832.9M | 4.51% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 12,793,060 | $781.5M | 4.24% |
| FLOSSBACH VON STORCH SE | 12,107,839 | $739.7M | 4.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 9,146,341 | $556.8M | 3.03% |
| Invesco Ltd. | 8,899,584 | $543.7M | 2.95% |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | 8,635,231 | $527.5M | 2.86% |
| NORGES BANK | 7,339,514 | $448.4M | 2.43% |
| GOLDMAN SACHS GROUP INC | 4,259,072 | $260.2M | 1.41% |
| UBS Group AG | 4,251,552 | $259.7M | 1.41% |
| NORDEA INVESTMENT MANAGEMENT AB | 4,169,025 | $253.9M | 1.38% |
| BARCLAYS PLC | 3,693,082 | $225.6M | 1.22% |
Institutional ownership by quarter
Holder changes by quarter
| Quarter | Holders | Ownership | New | Increased | Reduced | Closed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 809 | 109.0% | 95 | 251 | 310 | 57 |
| 2026-03-31 | 780 | 105.8% | 94 | 254 | 261 | 80 |
| 2025-12-31 | 780 | 107.8% | 135 | 214 | 295 | 69 |
| 2025-09-30 | 730 | 103.8% | 76 | 214 | 308 | 127 |
| 2025-06-30 | 792 | 108.1% | 89 | 288 | 298 | 121 |
| 2025-03-31 | 837 | 147.3% | 91 | 262 | 339 | 84 |
| 2024-12-31 | 844 | 144.5% | 106 | 262 | 314 | 82 |
| 2024-09-30 | 838 | 142.8% | 91 | 290 | 309 | 74 |
| 2024-06-30 | 829 | 144.6% | 72 | 328 | 279 | 91 |
| 2024-03-31 | 860 | 145.2% | 107 | 289 | 294 | 48 |
| 2023-12-31 | 810 | 145.7% | 112 | 262 | 285 | 56 |
| 2023-09-30 | 767 | 148.8% | 81 | 255 | 261 | 50 |
Schedule 13D / 13G filers
| Filed | Form | Filer | % of class | Shares |
|---|---|---|---|---|
| 2026-05-15 | SCHEDULE 13G/A | T. Rowe Price Associates, Inc. | 7.7% | 23,751,512 |
| 2026-05-15 | SCHEDULE 13G/A | Shabet Rose Sharon | 7.1% | 22,479,388 |
| 2026-04-29 | SCHEDULE 13G | Vanguard Capital Management | 7.6% | 23,387,301 |
| 2026-03-26 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 |
ETFs with the largest holding
| ETF | Weight in fund | Holding value |
|---|---|---|
| VITSX | 0.02% | $524.4M |
| VTSAX | 0.02% | $524.4M |
| VTI | 0.02% | $524.4M |
| VSMPX | 0.02% | $524.4M |
| VFINX | 0.03% | $434.8M |
| VOO | 0.03% | $434.8M |
Share structure
Income statement
Fiscal years, USD| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $5.3B | $5.8B | $6.1B | $6.2B | $5.1B |
| Cost of revenue | $2.2B | $2.5B | $2.5B | $2.5B | $2.0B |
| Gross profit | $3.0B | $3.4B | $3.6B | $3.7B | $3.1B |
| R&D | $354.8M | $401.5M | $397.8M | $414.0M | $342.3M |
| SG&A | $1.8B | $2.0B | $2.1B | $2.1B | $1.9B |
| Operating income | $831.5M | $1.0B | $1.1B | $1.2B | $908.9M |
| EBITDA | $1.2B | $1.4B | $1.6B | $1.7B | $1.2B |
| Pretax income | $677.5M | $873.5M | $990.8M | $969.6M | $753.9M |
| Income tax | $63.3M | $118.3M | $125.0M | $136.7M | $112.7M |
| Net income | $608.4M | $755.2M | $865.8M | $832.9M | $579.2M |
| EPS, diluted | $1.63 | $2.09 | $2.43 | $2.36 | $1.74 |
| Diluted shares | 352.3M | 360.8M | 355.6M | 352.8M | 319.4M |
Balance sheet
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash & short-term investments | $819.3M | $709.2M | $1.9B | $813.3M | $375.5M |
| Receivables | $930.2M | $958.5M | $960.8M | $945.4M | $683.6M |
| Inventory | $512.7M | $536.7M | $536.9M | $544.8M | $291.8M |
| Total current assets | $2.5B | $2.5B | $3.7B | $2.6B | $1.6B |
| PP&E, net | $395.5M | $421.9M | $439.8M | $433.1M | $269.8M |
| Goodwill & intangibles | $13.0B | $12.5B | $12.3B | $13.5B | $9.5B |
| Total assets | $16.5B | $15.9B | $16.9B | $17.0B | $11.7B |
| Accounts payable | $557.9M | $623.0M | $608.6M | $677.4M | $436.4M |
| Total current liabilities | $3.7B | $2.7B | $1.8B | $2.2B | $2.2B |
| Long-term debt | $1.8B | $2.3B | $3.6B | $3.3B | $2.3B |
| Total liabilities | $6.9B | $6.2B | $6.6B | $6.8B | $5.3B |
| Shareholders' equity | $9.5B | $9.7B | $10.3B | $10.2B | $6.5B |
Cash flow statement
Outflows are negative| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | $614.2M | $755.2M | $865.8M | $832.9M | $579.2M |
| Depreciation & amortization | $395.5M | $465.6M | $456.8M | $543.9M | $437.6M |
| Stock-based compensation | $77.4M | $93.8M | $113.3M | $109.2M | $116.8M |
| Change in working capital | −$111.5M | −$20.6M | $21.8M | $103.9M | −$399.9M |
| Operating cash flow | $961.1M | $1.3B | $1.4B | $1.5B | $1.1B |
| Capital expenditure | −$50.0M | −$95.8M | −$107.8M | −$120.4M | −$105.1M |
| Free cash flow | $911.1M | $1.2B | $1.2B | $1.4B | $978.1M |
| Investing cash flow | −$2.6B | −$102.5M | −$195.4M | −$1.8B | −$135.4M |
| Net debt issued / repaid | $753.6M | −$723.9M | $389.2M | $137.0M | −$714.8M |
| Buybacks | $0 | −$442.9M | −$272.9M | −$889.6M | −$1.6B |
| Dividends paid | −$132.2M | −$99.5M | −$102.0M | −$111.2M | −$92.2M |
Ratio history
Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Gross margin | 57.2% | 57.7% | 59.3% | 59.9% | 61.0% |
| Operating margin | 15.5% | 17.3% | 19.0% | 18.4% | 17.7% |
| Net margin | 11.6% | 13.0% | 14.3% | 13.4% | 11.3% |
| FCF margin | 17.3% | 20.7% | 20.5% | 22.6% | 19.0% |
| ROE | 6.6% | 7.9% | 8.7% | 8.1% | 7.0% |
| ROIC | 5.7% | 7.0% | 8.2% | 7.4% | 8.8% |
| ROA | 3.7% | 4.7% | 5.3% | 4.9% | 4.0% |
| Debt / equity | 0.44 | 0.35 | 0.37 | 0.38 | 0.50 |
| Interest coverage | 7.6x | 9.9x | 9.0x | 7.3x | 7.0x |
| Current ratio | 0.68 | 0.91 | 2.05 | 1.16 | 0.71 |
| Revenue growth | +13.4% | +10.9% | +4.1% | +2.7% | −17.5% |
| EPS growth | −62.5% | +26.3% | +15.4% | −2.0% | −24.2% |
| P/E at year end | 33.7x | 22.6x | 22.5x | 23.5x | 30.4x |
| EV / EBITDA at year end | 20.3x | 13.7x | 13.6x | 13.6x | 15.9x |
| FCF yield at year end | 4.44% | 7.08% | 6.39% | 7.18% | 5.55% |
| Dividend payout | 21.7% | 13.2% | 11.8% | 13.4% | 15.9% |
Revenue by segment
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Intelligent Operating Solutions | $2.2B | $2.5B | $2.6B | $2.7B | $2.9B |
| Precision Technologies | $1.8B | $2.0B | $2.1B | $2.2B | — |
| Advanced Healthcare Solutions | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B |
Revenue by region · FY2024
Street estimates by fiscal year
Next report 2026-10-28 · consensus EPS $0.70 · these are analysts' numbers, not ours| Fiscal year | Revenue (mean) | Revenue range | EPS (mean) | EPS range | Analysts | P/E on mean EPS |
|---|---|---|---|---|---|---|
| 2026 | $4.4B | $4.3B – $4.4B | $3.01 | $2.94 – $3.04 | 10 | 19.2x |
| 2027 | $4.5B | $4.5B – $4.6B | $3.25 | $3.18 – $3.31 | 9 | 17.8x |
| 2028 | $4.7B | $4.6B – $4.7B | $3.49 | $3.37 – $3.68 | 4 | 16.5x |
Reported vs expected, every quarter on file
| Reported | EPS expected | EPS actual | EPS surprise | Revenue expected | Revenue actual | Revenue surprise |
|---|---|---|---|---|---|---|
| 2026-07-29 | $0.71 | $0.74 | +4.7% | $1.1B | $1.1B | +2.6% |
| 2026-04-30 | $0.64 | $0.70 | +8.9% | $1.0B | $1.1B | +3.0% |
| 2026-02-04 | $0.84 | $0.90 | +7.4% | $1.1B | $1.1B | +2.6% |
| 2025-10-29 | $0.57 | $0.68 | +19.5% | $1.0B | $1.0B | +1.9% |
| 2025-07-30 | $0.58 | $0.58 | −0.9% | $1.0B | $1.5B | +49.9% |
| 2025-05-01 | $0.64 | $0.85 | +32.6% | $1.5B | $1.5B | −1.2% |
| 2025-02-07 | $1.12 | $1.17 | +4.5% | $1.6B | $1.6B | −0.5% |
| 2024-10-30 | $0.93 | $0.97 | +4.2% | $1.6B | $1.5B | −1.2% |
| 2024-07-24 | $0.92 | $0.93 | +1.2% | $1.6B | $1.6B | −0.8% |
| 2024-04-24 | $0.80 | $0.83 | +4.1% | $1.5B | $1.5B | −0.2% |
| 2024-01-31 | $0.93 | $0.98 | +5.4% | $1.6B | $947.5M | −39.4% |
| 2023-10-25 | $0.86 | $0.85 | −1.2% | $1.5B | $1.5B | −1.6% |
| 2023-07-26 | $0.81 | $0.85 | +4.9% | $1.5B | $1.5B | +1.2% |
| 2023-04-26 | $0.73 | $0.75 | +2.7% | $1.4B | $1.5B | +2.7% |
| 2023-02-01 | $0.84 | $0.88 | +4.8% | $1.5B | $1.5B | +1.9% |
| 2022-10-26 | $0.76 | $0.79 | +3.9% | $1.4B | $1.5B | +0.9% |
| 2022-07-28 | $0.72 | $0.78 | +8.3% | $1.4B | $1.5B | +4.3% |
| 2022-04-28 | $0.68 | $0.70 | +2.9% | $1.3B | $1.4B | +2.2% |
| 2022-02-03 | $0.78 | $0.79 | +1.3% | $1.4B | $1.4B | −4.4% |
| 2021-10-28 | $0.65 | $0.66 | +1.5% | $1.3B | $1.3B | −1.4% |
| 2021-07-29 | $0.61 | $0.66 | +8.2% | $1.3B | $1.3B | 0.0% |
| 2021-04-29 | $0.60 | $0.63 | +5.0% | $1.2B | $1.3B | +3.3% |
| 2021-02-04 | $0.61 | $0.70 | +14.8% | $1.3B | $1.3B | +2.9% |
| 2020-10-27 | $0.88 | $0.94 | +6.8% | $1.7B | $1.9B | +8.8% |
Off-exchange (dark pool) volume, weekly
FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)| Week of | Notional | Shares | Trades |
|---|---|---|---|
| 2026-08-31 | $165.8M | 2,883,814 | 59,370 |
| 2026-08-24 | $128.9M | 2,145,580 | 53,204 |
| 2026-08-17 | $132.0M | 2,205,633 | 52,887 |
| 2026-08-10 | $117.0M | 1,898,356 | 53,291 |
| 2026-08-03 | $173.6M | 2,856,757 | 74,325 |
| 2026-07-27 | $433.1M | 7,130,025 | 107,816 |
Short-sale share of off-exchange volume
daily 20-day average| Date | Short share | Short volume | Total volume |
|---|---|---|---|
| 2026-10-15 | 70.4% | 420,228 | 596,492 |
| 2026-10-14 | 58.4% | 403,395 | 691,144 |
| 2026-10-13 | 71.0% | 545,670 | 768,346 |
| 2026-10-12 | 76.2% | 214,452 | 281,410 |
| 2026-10-09 | 70.6% | 401,384 | 568,585 |
| 2026-10-08 | 69.5% | 490,008 | 704,771 |
| 2026-10-07 | 74.7% | 387,842 | 518,948 |
| 2026-10-06 | 69.5% | 510,694 | 735,165 |
| 2026-10-05 | 61.1% | 555,919 | 909,675 |
| 2026-10-02 | 72.6% | 560,491 | 772,241 |
Seasonality
Average return by calendar month| Month | Avg return | Up years | Years |
|---|---|---|---|
| Jan | +2.7% | 60% | 10 |
| Feb | +1.4% | 60% | 10 |
| Mar | −2.6% | 60% | 10 |
| Apr | −1.3% | 33% | 9 |
| May | +0.5% | 78% | 9 |
| Jun | +2.3% | 67% | 9 |
| Jul | +2.0% | 60% | 10 |
| Aug | +2.2% | 70% | 10 |
| Sep | +0.3% | 50% | 10 |
| Oct | −1.7% | 50% | 10 |
| Nov | +5.1% | 90% | 10 |
| Dec | −0.4% | 50% | 10 |
Indicators
as of 2026-10-16Moving averages and bands
level (price vs level)About Fortive Corporation
Fortive Corporation is a global industrial technology company that specializes in the conception, development, manufacturing, marketing, and servicing of sophisticated professional and engineered products, as well as software platforms and associated services. Its Intelligent Operating Solutions division aims to boost efficiency and safety in operations. This segment delivers a variety of offerings, including advanced tools for ensuring equipment reliability, comprehensive enterprise software for managing environmental, health, safety, and quality (EHSQ) compliance, and specialized software for the entire lifecycle of facilities and assets. It also provides solutions for pre-construction planning and procurement, robust professional testing instruments, precise calibration tools for electrical, pressure, and temperature measurements, and portable devices for gas detection. These products and services cater to diverse industries such as manufacturing, process industries, healthcare, utilities and power generation, communications, and electronics. Key brands within this segment include ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL. The company's Precision Technologies segment focuses on delivering critical measurement and control solutions. Its portfolio encompasses electrical testing and measurement instruments and related services, high-performance energetic material devices, and advanced sensor and control system solutions. These technologies are crucial for demanding sectors like power and energy management, medical equipment manufacturing, food and beverage production, aerospace and defense, off-highway vehicles, electronics, semiconductor fabrication, and various other industrial applications. This segment markets its offerings under brands such as ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX. Fortive's Advanced Healthcare Solutions division provides a comprehensive suite of hardware, software, and services specifically designed for the healthcare sector. This includes solutions for reprocessing and tracking medical instruments and devices, specialized biomedical testing tools, systems for radiation safety monitoring, and asset management services. Additionally, it offers subscription-based surgical inventory management platforms that optimize inventory and ensure regulatory adherence, alongside expert technical, analytical, and compliance services focused on determining radiation exposure. Brands in this segment include ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD. Established in 2015, Fortive Corporation maintains its corporate headquarters in Everett, Washington.
Key executives
| Name | Title | Pay | Born |
|---|---|---|---|
| Mark D. Okerstrom | Senior Vice President & Chief Financial Officer | $3.0M | 1973 |
| Olumide Soroye | President, Chief Executive Officer & Director | $2.5M | 1973 |
| Amee Desjourdy | Senior Vice President & Chief People Officer | $1.4M | 1973 |
| Peter C. Underwood | Senior Vice President & Chief Legal Officer | $1.3M | 1970 |
| Arul Elumalai | President of Gordian and Group President of Facilities & Asset Lifecycle (FAL) Group | — | — |
| Chad Rohrer | President of ASP & Group President of Infection Prevention Group (IPG) | — | — |
| Christina Jones | Vice President of Investor Relations | — | — |
| Christopher Mulhall | Chief Accounting Officer | — | 1974 |
Executive pay, latest proxy
| Executive | Year | Salary | Stock awards | Incentive | Total |
|---|---|---|---|---|---|
| Mark D. Okerstrom Senior Vice President, Chief Financial Officer | 2025 | $600,000 | $13.7M | $1.0M | $21.4M |
| Olumide O. Soroye President and Chief Executive Officer | 2025 | $931,733 | $8.2M | $1.4M | $14.4M |
| James A. Lico Former President and Chief Executive Officer | 2025 | $1.2M | $5.7M | $1.2M | $10.5M |
| Stacey A. Walker Former Senior Vice President, Chief People Officer (through January 2, 2026) | 2025 | $625,000 | $3.0M | $577,125 | $5.4M |
| Tamara Newcombe Former President and CEO, Precision Technologies | 2025 | $436,539 | $2.2M | $0 | $5.4M |
| Peter C. Underwood Senior Vice President, Chief Legal Officer | 2025 | $630,000 | $2.8M | $570,402 | $5.1M |
Employees
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| 2026-09-04 | $0.07 | 2026-09-25 |
| 2026-06-22 | $0.06 | 2026-07-06 |
| 2026-03-13 | $0.06 | 2026-03-27 |
| 2025-11-28 | $0.06 | 2025-12-26 |
| 2025-09-12 | $0.06 | 2025-09-26 |
| 2025-05-30 | $0.06027 | 2025-06-27 |
| 2025-02-28 | $0.06027 | 2025-03-28 |
| 2024-11-29 | $0.06027 | 2024-12-27 |